MRFR a leading research company has published a momentoius research study on “Animal Model Market –Global Forecast to 2027”
A Innovative Study of “Animal Model Market-Global Forecast to 2027” has been published by market overview, Business Dynamics
The growth of the global animal model market is driven by various factors, such as the growing use in biomedical research to develop new treatment methods, to understand biocompatibility during drug development and cellular responsiveness of the implant at an early stage. Due to all these factors, the demand for animal models is growing in the healthcare sectors. There are large numbers of players involved in the development of new animal model technologies. Some of the key companies operating in this market are Janvier Labs, GenOway S.A., Charles River Laboratories, Taconic Laboratories, and others.
According to MRFR analysis, Global Animal Model Market is expected to register a CAGR of 7.8% during the forecast period of 2020 to 2027 and is anticipated to reach USD 3,632.48 Million by 2027.
However, alternatives such as cell cultures, computer models, & tissue cultures and also the ethical issues on using animals for research activities hamper the market growth.
Janvier Labs (France), GenOway S.A. (France), Envigo (US), Charles River Laboratories (UK), Taconic Laboratories (UK), Transgenic, Inc. (Japan), SAGE Labs (US), Horizon Discovery (England), Crown Bioscience Inc. (US), Harbor Antibodies Bv (A Subsidiary of Harbor BioMed) (Massachusetts)
· The global Animal Model Market has been segmented based on animal type, technology, application, and end-users.
· The global animal model market has been segmented, on the basis of animal type, into pigs, mice, rats, rabbits, and others. The rat segment is expected to hold the maximum share of the market throughout the forecast period. The rabbit segment is expected to be the fastest-growing during the assessment period. On the basis of technology, the market is segmented into CRISPR and other technologies. Based on CRISPR the market has been segmented into microinjection and electroporation.
· Based on the application, the market is segmented research and development and production and quality control. Research and development have been further sub-segmented into cardiovascular, infectious diseases, metabolic diseases, immunological diseases, cancer, diabetes, genetic diseases, neurological diseases, and others.
· On the basis of end-user, the market is segmented into research institutes, educational institutes, pharmaceutical companies, and contract research organizations.
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The animal model market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The Americas is expected to be the largest market owing to the presence of a large number of companies providing animal models such as Crown Bioscience Inc., Envigo, Harbor Antibodies Bv, and many more. Additionally, the rising demand for the use of non-human models in scientific research contributes to the growing animal model market in this region. According to the US government statistics around 780,070 number of laboratory animals were used in research in 2018, which has been increased by 5.7% from 2017. The increasing use of animal models drives market growth in this region.
The European animal model market is the fastest-growing market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The increasing R&D to develop novel vaccines, rising use in cancer and Alzheimer's research, and growing funding for research activity boosts the market growth. The European Community supports research activity by providing sufficient funding. The European Community has funded around USD 10.79 to 11.87 million for 4 to 5 years for the research studies. Additionally, it was reported that the German Federal Ministry of Food and Agriculture, (BMEL) reported that around 2.825.066 animals were used for research purposes in Germany in 2018 which enhances the market growth.
Access Full Report Details @ https://www.marketresearchfuture.com/reports/animal-model-market-9709
The animal model market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing preference for animal models for research activities and the growing number of healthcare care companies (Merck KGaA, GenOway S.A., Horizon Discovery and among others) drives the market growth in this region. The animal model market in the Middle East & Africa has been divided into the Middle East and Africa. The growing number of research laboratories in this region drives market growth.